Bayer AG Pharmaceuticals Division (Berlin). 2024 revenue ~€18B. Eylea (aflibercept), Xarelto, Aspirin. Radiology: Ultravist, Gadovist. Cell & Gene Therapy. Women's health: Mirena, Kyleena.
帝人
@teijin
Process verification replaced traditional three-batch validation across our manufacturing network.
Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.
L'Oréal R&D (Clichy, France). 2024 revenue ~€43B. Cosmetic chemistry: polymers, emulsifiers, UV filters (Mexoryl SX/XL), peptides. Redermic, Revitalift. Active cosmetics: La Roche-Posay, CeraVe. 88K employees.
POSCO Chemical (Pohang, South Korea). 2024 revenue ~KRW4T. Needle coke, coal tar pitch for steelmaking. Battery materials: artificial graphite anode, NCM cathode. Carbon materials. Part of POSCO Holdings.
Clariant Catalysts Division (München, Deutschland). Syngas catalysts (methanol, FT), petrochemical catalysts (dehydrogenation, oxychlorination). SUNOX VOC catalysts. Custom catalyst development.
LG Energy Solution (Seoul). 2024 revenue ~KRW26T. World's #2 EV battery maker. NCM pouch, LFP prismatic, ESS storage. Tesla, GM, Hyundai, Stellantis supplier. Cathode materials (high-nickel NCM). 30K employees.